abrdn Healthcare Investors
abrdn Healthcare Investors (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life sciences tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.
Stock Performance Snapshot
Financial Health
abrdn Healthcare Investors has modest revenue and low profit margins, indicating average financial performance.
Dividend
abrdn Healthcare Investors offers a high dividend yield of 11.89%, making it appealing for those seeking income. If you invested $1000 you would be paid $118.90 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring HQH
Economic Diversification Champions
Invest in the ambitious transformation of Gulf nations moving beyond oil dependency. These carefully selected companies are at the forefront of building new economic pillars in technology, finance, and infrastructure, backed by massive government investment programs.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Active healthcare picks
Manager selects concentrated positions across pharma, biotech and devices to capture innovation-led growth, though concentrated exposure can increase volatility.
Global sector exposure
Invests internationally across regions and sub‑sectors, offering diversification within healthcare while remaining exposed to different regulatory and currency risks.
R&D-driven outcomes
Healthcare returns often hinge on clinical trials and approvals — potential for strong upside but also binary downside risks for individual stocks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
